Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evidence for human diabetic cardiomyopathy.
Marfella R, Sardu C, Mansueto G, Napoli C, Paolisso G. Marfella R, et al. Among authors: paolisso g. Acta Diabetol. 2021 Aug;58(8):983-988. doi: 10.1007/s00592-021-01705-x. Epub 2021 Mar 31. Acta Diabetol. 2021. PMID: 33791873 Free PMC article. Review.
Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.
Marfella R, Amarelli C, Cacciatore F, Balestrieri ML, Mansueto G, D'Onofrio N, Esposito S, Mattucci I, Salerno G, De Feo M, D'Amico M, Golino P, Maiello C, Paolisso G, Napoli C. Marfella R, et al. Among authors: paolisso g. J Am Coll Cardiol. 2020 Mar 24;75(11):1249-1262. doi: 10.1016/j.jacc.2020.01.018. J Am Coll Cardiol. 2020. PMID: 32192650 Free article.
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts.
Marfella R, D'Onofrio N, Trotta MC, Sardu C, Scisciola L, Amarelli C, Balestrieri ML, Grimaldi V, Mansueto G, Esposito S, D'Amico M, Golino P, Signoriello G, De Feo M, Maiello C, Napoli C, Paolisso G. Marfella R, et al. Among authors: paolisso g. Metabolism. 2022 Feb;127:154936. doi: 10.1016/j.metabol.2021.154936. Epub 2021 Nov 18. Metabolism. 2022. PMID: 34801581 Free article. Clinical Trial.
Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study.
Sasso FC, Marfella R, Pagano A, Porta G, Signoriello G, Lascar N, Minutolo R, Carbonara O, Persico M, Piscione F, De Nicola L, Torella R, Paolisso G. Sasso FC, et al. Among authors: paolisso g. Acta Diabetol. 2015 Apr;52(2):239-47. doi: 10.1007/s00592-014-0623-x. Epub 2014 Aug 11. Acta Diabetol. 2015. PMID: 25109286 Clinical Trial.
573 results